Literature DB >> 10509210

What is appropriate disclosure?

D Cohen.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10509210      PMCID： PMC2328522     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  3 in total

1.  Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.

Authors:  D V Jeste; J P Lacro; B Palmer; E Rockwell; M J Harris; M P Caligiuri
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

2.  Incidence and risk factors for severe tardive dyskinesia in older patients.

Authors:  M P Caligiuri; J P Lacro; E Rockwell; L A McAdams; D V Jeste
Journal:  Br J Psychiatry       Date:  1997-08       Impact factor: 9.319

3.  Informed consent for antipsychotic medication.

Authors:  D Schachter; I Kleinman; J I Williams
Journal:  Can Fam Physician       Date:  1999-06       Impact factor: 3.275
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.